Table:
begin	end	state
1	27	cytoplasmic
28	46	transmembrane
47	65	non-cytoplasmic
66	85	transmembrane
86	96	cytoplasmic
97	117	transmembrane
118	122	non-cytoplasmic
123	147	transmembrane
148	157	cytoplasmic
158	179	transmembrane
180	190	non-cytoplasmic
191	213	transmembrane
214	255	cytoplasmic
256	277	transmembrane
278	288	non-cytoplasmic
289	310	transmembrane
311	321	cytoplasmic
322	341	transmembrane
342	346	non-cytoplasmic
347	367	transmembrane
368	373	cytoplasmic
374	398	transmembrane
399	413	non-cytoplasmic
414	434	transmembrane
435	439	cytoplasmic

Input:
>BPHYT_RS05360 FitnessBrowser__BFirm:BPHYT_RS05360
MASPANPLHHPGAGAPPSTFEEATYRKVSWRLAPLLMLCYVVAYLDRVNVGFAKLQMTSD
LGLSDAVYGFGAGIFFVGYFIFEIPSNVILHKVGARVWIARIMVSWGVISMLTMFVTTPT
MFYVMRFLLGLAEAGFFPGIILYLTYWYPAHRRGRMTTWFMTAIALSGVIGGPVSGYILK
TFNGMNGWHGWQWLFLLEGIPSVIVGIMVFTMLDDRISKAKWLTKEEQQLLERHVSAEEA
TKHDMPIRQVLTSGRVLMLSLTYFSFVMGLYGVSFWLPTIIKATGVTDAFMIGLLSAIPF
AGAVVAMVFVSRSADRKRERRWHIALPAFAGAVGLVLSVVWAHNTVLAMASLTLATMGIL
TTLPLFWSLPTAILAGTGAAAGIAMINSIGNLAGFLSPYAVGWLKQATAANDSGMYMLAA
FMVLGGLLAISVPAKMVNK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server